Mirzotamab Antibody
Mirzotamab is a naked IgG1κ monoclonal antibody targeting the immune checkpoint protein CD276/B7-H3. As the unconjugated form of Mirzotamab clezutoclax, it is a key research tool for investigating B7-H3 function in oncology and immunology through in vitro binding assays and in vivo model studies.
Product Specifications
Product Name Alternative
Inflammation related, Inflammationrelated, Immunology related, Immunologyrelated, CD276/B7-H3
Target
B7, Immunology/Inflammation related, ADC Antibody
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
16.85 mg/mL
Purity
97.37% (May vary between batches)
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-4062R-BF594 100 µL
Glycerol kinase Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 